Rxo (RXO) Other financing activities (2021 - 2025)

Rxo (RXO) has 5 years of Other financing activities data on file, last reported at -$10.0 million in Q2 2025.

• For the quarter ending Q2 2025, Other financing activities fell 900.0% year-over-year to -$10.0 million; the trailing twelve-month figure through Mar 2026 stood at -$10.0 million (down 133.33% YoY), and the FY2025 full-year result was -$10.0 million, down 133.33% from the prior year.
• Other financing activities for Q2 2025 stood at -$10.0 million, down from $21.0 million in the prior quarter.
• Across five years, Other financing activities topped out at $21.0 million in Q4 2024 and bottomed at -$10.0 million in Q2 2025.
• The 5-year median for Other financing activities is $1.0 million (2022), against an average of $3.1 million.
• The widest annual swing landed in 2022, when Other financing activities surged 900.0%; it then sank 900.0% in 2025.
• A 5-year view of Other financing activities shows it stood at -$1.0 million in 2021, then soared by 900.0% to $8.0 million in 2022, then slumped by 87.5% to $1.0 million in 2023, then soared by 2000.0% to $21.0 million in 2024, then sank by 147.62% to -$10.0 million in 2025.
• The last three Other financing activities figures came in at -$10.0 million (Q2 2025), $21.0 million (Q4 2024), and $10.0 million (Q3 2024), per Business Quant data.

Peer Comparison